BALPHARMA.NSBALPHARMA.NSNSE
Loading
EPS Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P29
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-2.98%
2024186.59%
2023-56.73%
202213.47%
2021138.75%
2020-422.85%
201936.22%
201858.06%
201713.76%
2016-61.48%